Sentara Leigh Clinical Trial
Reveals Significant Reductions in MDROs and C. difficile
%
Reduction in MDROs
%
Reduction in C. diff
Evaluating the Clinical Benefits of EOScu
EOS Surfaces and Cupron joined with Sentara Healthcare to evaluate the clinical and economic effectiveness of installing EOScu Preventive|Biocidal surfaces and antimicrobial textiles in a range of healthcare environments.

The Trial
Committed to combating the spread of pathogens that contribute to healthcare infections, EOScu Preventive|Biocidal Surface™ and Cupron-enhanced textiles are being evaluated at multiple sites. The study will assess the improvement of patient outcomes and reduction of healthcare costs.
This comprehensive trial is the world’s largest known hospital evaluation of biocidal materials to date.
The location
The trial started in April 2014 at Sentara Norfolk, and will be followed by a large-scale study taking place at Sentara Leigh Hospital in Norfolk, VA.

The large-scale Trial includes:
- The installation of more than 15,000 horizontal square feet of patent-pending EOScu Preventive|Biocidal surfaces
- Preventive|Biocidal hard surfaces installed on virtually all clinical and patient-room surfaces, including over bed tables and bed rails
- Anti-odor textiles manufactured by the Encompass Group are used for patient bed linens, patient gowns, and other textiles

See the EOScu difference
Request a sample today